Aardvark Therapeutics, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
▼ Likely negative
significance 28/100
What the filing says
Aardvark granted retention bonuses to Nelson Sun ($346,500: $198,000 guaranteed 2026 bonus + $148,500 retention component) and Manasi Jaiman, M.D., M.P.H. ($357,000: $204,000 guaranteed bonus + $153,000 retention component), both dated June 10, 2026, payable January 1, 2027, contingent on continued employment through that date. Total commitment: $703,500. Bonuses are forfeitable if employment terminates, except for termination without Cause or resignation for Good Reason (which triggers payment 60 days post-termination upon release execution).
Why this rating
Routine executive retention spend (~0.43% of $162.9M market cap). Standard practice for early-stage biotech to retain senior talent; amounts reflect typical compensation, not a strategic shift or crisis signal.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.